Anti-apoptotic mechanism of ursodeoxycholic acid (UDCA) on hypoxic cardiomyocytes
Ursodeoxycholic acid (UDCA), the most hydrophilic bile acid is used as a therapeutic agent in liver related diseases and to eliminate hydrophobic bile acid induced apoptosis in liver. Recently, studies suggested the potential used of UDCA in treating heart related diseases. UDCA is reported cardiopr...
Saved in:
Main Author: | |
---|---|
Format: | Thesis Book |
Language: | English |
Published: |
Sungai Buloh, Selangor
Universiti Teknologi MARA. Faculty of Medicine
2017
|
Subjects: | |
Online Access: | Click Here to View Status and Holdings. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000nam a2200000#i 4501 | ||
---|---|---|---|
001 | wils-976834 | ||
005 | 202217145221 | ||
008 | 220208t20172017 MY df #000 deng D | ||
040 | # | # | |a UiTM |c UiTM |e rda |
041 | 0 | # | |a English |
060 | 0 | 0 | |a WI 703 |
090 | 0 | 0 | |a WI703 |b N818a 2017 |
100 | 0 | # | |a Noorul Izzati Hanafi |e author |
245 | 1 | 0 | |a Anti-apoptotic mechanism of ursodeoxycholic acid (UDCA) on hypoxic cardiomyocytes |c Noorul Izzati Hanafi |
264 | # | 1 | |a Sungai Buloh, Selangor |b Universiti Teknologi MARA. Faculty of Medicine |c 2017 |
264 | # | 4 | |c ©2017 |
300 | # | # | |a xx, 148 pages |b illustrations (some color), charts, 3 pages of plates |c 30 cm |
336 | # | # | |a text |b txt |2 rdacontent |
337 | # | # | |a unmediated |b n |2 rdamedia |
338 | # | # | |a volume |b nc |2 rdacarrier |
500 | # | # | |a UiTM Digitized |
502 | # | # | |a Thesis (MSc.)--Universiti Teknologi MARA. Faculty of Medicine, 2017 |
504 | # | # | |a Includes bibliographical references (page 108-133) |
520 | # | # | |a Ursodeoxycholic acid (UDCA), the most hydrophilic bile acid is used as a therapeutic agent in liver related diseases and to eliminate hydrophobic bile acid induced apoptosis in liver. Recently, studies suggested the potential used of UDCA in treating heart related diseases. UDCA is reported cardioprotective against the development of ischemia. However, the mechanism of action in UDCA-cardioprotection is not clearly understood. Therefore, this study aimed to determine the anti-apoptotic mechanisms of UDCA on cardioprotection using an in vitro hypoxic model of neonatal rat cardiomyocytes. Rat heart from newborn (0-2 days old) was isolated for primary cell culture of cardiomyocytes. Hypoxia was induced by using C0CI2 and hypoxic chamber. Cardiomyocytes were incubated with UDCA (pre-UDCA and post-UDCA) and coincubated with FTY720 (SIP receptor agonist), PTX (Ga; inhibitor). The treated cardiomyocytes were subjected for proliferation assay (MTS assay), beating assessment assay, protein expression (aSMase and nSMase, Hif-la, caspase-3 and caspase-9, ERK and Akt), ROS generation assay and gene expression {Hif-la, smpdl, smpd2, caspase-3, caspase-9). The data were analyzed by using sample paired t-test and One-way ANOVA. MTS assay revealed that UDCA was not toxic to cardiomyocytes even at high concentration (250 urn). Results showed that C0CI2 activates Hif-la expression, reduces cell viability; reduce beating rate, upregulates nSMase protein, increases ROS production, downregulates ERK and Akt protein expression. Interestingly, pre-UDCA treatment significantly abolished the negative effects of C0CI2 on cell viability, beating rate, ROS production, ERK and Akt expression in cardiomyocytes. Treatment with PTX partially inhibits the protection of UDCA against C0CI2 negatives effects on beating rate of cardiomyocytes. Meanwhile, FTY720 showed similarity with UDCA action in downregulating smpdl gene expression and upregulates caspase-9 gene expression. In conclusion, the current data suggests that UDCA mechanism is mediated partially through Gdi-coupled receptor dependent and independent pathways in protecting cardiomyocytes against hypoxia. This study provides an insight of anti-apoptotic mechanism of UDCA on hypoxic cardiomyocytes |
650 | 1 | 2 | |a Bile Acids and Salts |x immunology |
650 | 2 | 2 | |a Apoptosis |
650 | 2 | 2 | |a Apoptosis Regulatory Proteins |
650 | 2 | 2 | |a Hypoxia |x physiopathology |
710 | 2 | # | |a Faculty of Medicine |e issuing body |
856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=976834 |
998 | # | # | |a 00264#1a006.2.2||00264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00500##a006.2.2||00502##a006.2.2||00520##a006.2.2||00520##b006.2.2|| |